CellaVision AB (publ) CLVSF
Set alert
14.00 USD 0.00 0.00%
At close · Oct 30
13.49 Day range 15.00
13.49 52-week range 19.28
- YTD
- -16.82%
- 1 year
- -27.39%
- Open
- 15.00
- Prev close
- 14.00
- Mkt cap
- 333.92M
- Vol
- 400
- Avg vol
- 0
- EPS
- 0.58
- P/E
- 24.14
More statistics
- Low
- 13.49
- High
- 15.00
YTD chart
Events in this range
- Apr 29, 2026Dividend: 0.29734
- Apr 30, 2026Dividend: 0.2973
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| RSI: Overbought | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | May 14, 2026 | 5 months ago |
| SMA: Bearish | Apr 24, 2026 | 6 months ago |
| RSI: Oversold | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 9 months ago |
| RSI: Oversold | Feb 4, 2026 | 9 months ago |
| RSI: Overbought | Jan 21, 2026 | 9 months ago |
| SMA: Bullish | Jan 20, 2026 | 9 months ago |
Financial health
Altman Z-Score
9.03 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A-4 / 5 overall
- DCF 3
- Return on Equity 4
- Return on Assets 5
- Debt / Equity 4
- P/E 2
- P/B 2
Valuation
P/E 24.2×
FY 2016 5y median 47.1× FY 2025
P/S 4.9×
FY 2016 5y median 8.7× FY 2025
P/B 4.2×
FY 2016 5y median 8.4× FY 2025
P/FCF 32.4×
FY 2016 5y median 56.6× FY 2025
EV/EBITDA 14.4×
FY 2016 5y median 29.2× FY 2025
EV/Sales 4.7×
FY 2016 5y median 8.7× FY 2025
FCF Yield 3.1%
FY 2016 5y median 1.8% FY 2025
Profitability
Gross Margin 68.5%
FY 2016 5y median 68.5% FY 2025
Operating Margin 26.6%
FY 2016 5y median 24.8% FY 2025
Net Margin 20.2%
FY 2016 5y median 19.5% FY 2025
ROE 17.2%
FY 2016 5y median 18.2% FY 2025
ROIC 16.0%
FY 2016 5y median 15.8% FY 2025
ROA 14.0%
FY 2016 5y median 13.9% FY 2025
Growth (YoY)
Revenue 4.9%
FY 2016 FY 2025
Operating Income 13.7%
FY 2016 FY 2025
EPS (diluted) 8.8%
FY 2016 FY 2025
Free Cash Flow -5.3%
FY 2016 FY 2025
Financial Health
Current Ratio 4.0×
FY 2016 5y median 2.9× FY 2025
Quick Ratio 3.0×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.7×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 18.9×
FY 2016 5y median 67.6× FY 2025
Dividends
Dividend Yield 1.6%
FY 2016 5y median 0.9% FY 2025
Payout Ratio 39.0%
FY 2016 5y median 39.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
